Literature DB >> 25479576

Risk factors for infection and the effect of an institutional shunt protocol on the incidence of ventricular access device infections in preterm infants.

Heather S Spader1, Dean A Hertzler, John R W Kestle, Jay Riva-Cambrin.   

Abstract

OBJECT: Intraventricular hemorrhage in premature infants often leads to progressive ventricular dilation and the need for ventricular reservoir placement. Unfortunately, these reservoirs have a higher rate of infection than ventriculoperitoneal shunts in premature babies. The authors analyzed the risk factors for infection in this population and studied whether the implementation of an institutional protocol for shunt placement had a corollary effect on ventricular access device (VAD) infection rates in premature neonates with intraventricular hemorrhage.
METHODS: The authors conducted a retrospective cohort review of consecutive premature neonates in whom VADs were inserted in the operating room at Primary Children's Hospital between June 2003 and June 2011 to identify risk factors for infection. Medical records were reviewed for information on infection (culture proven or eroded hardware at 90 days), gestational age at birth, weight, gestational age at surgery, intrathecal antibiotics, hemorrhage, death, and surgeon. The institution used a pilot protocol for shunt infection reduction in 2006-2007, and then the full Hydrocephalus Clinical Research Network protocol from June 2007 to 2011, and the rates of infection during these periods were analyzed. Confounding factors such as sepsis, necrotizing enterocolitis, and a history of meningitis were also analyzed.
RESULTS: The overall infection rate was 10.5% (11 patients) in the 105 patients identified. Gestational age at procedure was a significant risk factor for infection (p=0.05). Meningitis was significantly associated with infection, with 63% of the infected group having had prior meningitis compared with 7% for the noninfected group (p<0.001). Concurrent with the implementation of the protocol to reduce shunt infection, the VAD infection rate decreased from 14.7% to 5.4% (p=0.2).
CONCLUSIONS: Gestational age at procedure and previous meningitis were significant risk factors for VAD infections. In addition, the implementation of an institutional standardized shunt protocol for ventriculoperitoneal shunts may have altered the operating room team's behavior, indicated by a nonmandated use of intrathecal antibiotics in VAD surgeries, contributing to a reduced VAD infection rate. Although the observed difference was not statistically significant with the small sample size, the authors believe that these findings deserve further study.

Entities:  

Keywords:  HCRN = Hydrocephalus Clinical Research Network; IT = intrathecal; IVH = intraventricular hemorrhage; NEC = necrotizing enterocolitis; PCH = Primary Children's Hospital; PPHVD = progressive posthemorrhagic ventricular dilation; VAD = ventricular access device; VP = ventriculoperitoneal; hydrocephalus; infection; ventricular access device; ventricular hemorrhage

Mesh:

Year:  2014        PMID: 25479576     DOI: 10.3171/2014.9.PEDS14215

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  9 in total

1.  Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network.

Authors:  Zohreh Habibi; Abolhasan Ertiaei; Mohammad Sadegh Nikdad; Atefeh Sadat Mirmohseni; Mohsen Afarideh; Vahid Heidari; Hooshang Saberi; Abdolreza Sheikh Rezaei; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 2.  Shunt Devices for Neurointensivists: Complications and Management.

Authors:  G Smith; J Pace; A Scoco; G Singh; K Kandregula; S Manjila; C Ramos-Estebanez
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 3.  Prophylactic antibiotics in pediatric neurological surgery.

Authors:  Friederike Knerlich-Lukoschus; Martina Messing-Jünger
Journal:  Childs Nerv Syst       Date:  2018-06-16       Impact factor: 1.475

4.  The role of simultaneous abdominal surgery and wound classification in ventriculoperitoneal shunt complication.

Authors:  Shin Miyata; Jamie Golden; Olga Lebedevskiy; James E Stein; David W Bliss
Journal:  Pediatr Surg Int       Date:  2017-09-30       Impact factor: 1.827

5.  TROPHY registry study design: a prospective, international multicenter study for the surgical treatment of posthemorrhagic hydrocephalus in neonates.

Authors:  Ulrich-Wilhelm Thomale; Giuseppe Cinalli; Abhaya V Kulkarni; Sara Al-Hakim; Jonathan Roth; Andreas Schaumann; Christoph Bührer; Sergio Cavalheiro; Spyros Sgouros; Shlomi Constantini; Hans Christoph Bock
Journal:  Childs Nerv Syst       Date:  2019-02-06       Impact factor: 1.475

6.  Does ventricle size contribute to cognitive outcomes in posthemorrhagic hydrocephalus? Role of early definitive intervention.

Authors:  Mounica Paturu; Regina L Triplett; Siddhant Thukral; Dimitrios Alexopoulos; Christopher D Smyser; David D Limbrick; Jennifer M Strahle
Journal:  J Neurosurg Pediatr       Date:  2021-10-15       Impact factor: 2.713

7.  Early elective delivery for fetal ventriculomegaly: are neurosurgical and medical complications mitigated by this practice?

Authors:  Clinton D Morgan; Travis R Ladner; George L Yang; Marjorie N Moore; Russell D Parks; William F Walsh; John C Wellons; Chevis N Shannon
Journal:  Childs Nerv Syst       Date:  2017-12-01       Impact factor: 1.475

8.  Risk factors for pediatric surgical site infection following neurosurgical procedures for hydrocephalus: a retrospective single-center cohort study.

Authors:  Thomas J Sandora; Koichi Yuki; Miho Shibamura-Fujiogi; Jennifer Ormsby; Mark Breibart; Benjamin Warf; Gregory P Priebe; Sulpicio G Soriano
Journal:  BMC Anesthesiol       Date:  2021-04-21       Impact factor: 2.217

9.  Ventricular Cerebrospinal Fluid Sampling in Pediatric Diffuse Midline Glioma Patients: Institutional Experience and Review of the Literature.

Authors:  Daphne Li; Wendy Stellpflug; Kathy Romanski; Maureen Kilgallon; Stacy Speck; Amanda M Saratsis
Journal:  Front Pediatr       Date:  2020-10-27       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.